Calculate the fetal biophysical profile score to assess fetal well-being. Includes all 5 parameters: breathing, movement, tone, amniotic fluid, and non-stress test.
About the BPP
The biophysical profile assesses fetal well-being through ultrasound and cardiotocography. Each parameter receives 0 or 2 points.
Normal, no evidence of fetal asphyxia
Routine follow-up based on clinical indication
| Parameter | Score | Status |
|---|---|---|
| Fetal breathing | 2/2 | Normal |
| Fetal movement | 2/2 | Normal |
| Fetal tone | 2/2 | Normal |
| Amniotic fluid | 2/2 | Normal |
| Non-stress test | 2/2 | Reactive |
| Score | Interpretation | Action |
|---|---|---|
| 8-10 | Normal | Routine follow-up |
| 6 | Equivocal | Repeat in 24 hours |
| 4 | Abnormal | Consider delivery |
| 0-2 | Severely abnormal | Immediate delivery |
This calculator is for educational purposes only. Clinical decisions should be made by qualified healthcare providers considering the full clinical picture.
The biophysical profile (BPP) is a comprehensive prenatal assessment tool that evaluates fetal well-being through a combination of ultrasound observations and electronic fetal heart rate monitoring. Developed in the early 1980s by Manning and colleagues, the BPP has become one of the most widely used methods for antepartum fetal surveillance, particularly in high-risk pregnancies where there is concern about fetal compromise.
The fundamental principle behind the BPP is that a healthy fetus demonstrates certain biophysical activities that are controlled by the central nervous system. When a fetus experiences hypoxia (oxygen deprivation) or acidosis, these activities become diminished or absent in a predictable sequence. By systematically evaluating these parameters, clinicians can identify fetuses at risk for adverse outcomes and intervene before permanent damage occurs.
The BPP serves as a window into fetal neurological function, providing real-time information about how the fetus is coping with its intrauterine environment. Unlike other tests that may only capture a single moment in time, the BPP evaluates both acute markers of fetal status (breathing, movement, tone, heart rate reactivity) and chronic indicators of placental function (amniotic fluid volume).
The biophysical profile was introduced in 1980 by Frank Manning and Lawrence Platt as a standardized approach to fetal assessment. Prior to the BPP, clinicians relied primarily on the non-stress test alone or clinical judgment based on maternal perception of fetal movement. The development of real-time ultrasound technology in the 1970s made it possible to directly observe fetal behaviors that had previously been invisible.
Manning and colleagues recognized that different fetal activities are controlled by different regions of the brain and develop at different gestational ages. They theorized that by combining multiple parameters into a single scoring system, clinicians could achieve better predictive accuracy than any single test alone. This concept of combining tests to improve diagnostic accuracy has since been validated in numerous studies involving tens of thousands of pregnancies.
The original BPP scoring system assigned 2 points for each normal parameter and 0 points for abnormal findings, creating a total possible score of 10. This straightforward binary scoring approach was designed to minimize inter-observer variability and make the test practical for busy clinical settings. Over four decades of use, the BPP has proven to be a reliable tool with excellent negative predictive value, meaning that a normal score is highly reassuring.
The biophysical profile evaluates five distinct parameters, four of which are assessed by ultrasound and one by external fetal monitoring. Each parameter is scored as either normal (2 points) or abnormal (0 points), with no intermediate scores. This binary approach simplifies interpretation but requires clear understanding of what constitutes normal findings.
Fetal breathing movements (FBM) are rhythmic movements of the fetal chest wall and diaphragm that resemble postnatal breathing, though obviously no air exchange occurs in utero. These movements typically appear as early as 10 weeks gestation but become more organized and sustained as the pregnancy progresses.
Normal finding (2 points): At least one episode of sustained rhythmic breathing lasting 30 seconds or longer within a 30-minute observation period. The breathing should demonstrate the characteristic "see-saw" motion of the chest and abdomen moving in opposite directions.
Abnormal finding (0 points): Absence of breathing movements or only isolated, brief episodes lasting less than 30 seconds throughout the observation period.
Clinical significance: Fetal breathing movements are highly sensitive to hypoxia and are typically among the first parameters to become absent when the fetus is compromised. The breathing center in the brainstem requires adequate oxygenation to function properly. Additionally, FBM are influenced by numerous physiological factors including time of day, maternal glucose levels, and fetal sleep-wake cycles. Breathing is typically more active in the afternoon and evening and may be suppressed following maternal meals or during fetal quiet sleep states.
Common causes of absent breathing: Besides fetal compromise, breathing movements may be absent during normal fetal sleep cycles (which can last 20-40 minutes), following maternal administration of certain medications (magnesium sulfate, sedatives, opioids), in cases of preterm gestations (breathing patterns are less organized before 34 weeks), and immediately following maternal corticosteroid administration for fetal lung maturity.
Gross fetal body movements, including limb movements and rolling or stretching motions, reflect the function of motor cortex and spinal cord pathways. Active, healthy fetuses typically demonstrate frequent spontaneous movements throughout the day, though movement patterns vary considerably between individual fetuses.
Normal finding (2 points): Three or more discrete episodes of body or limb movements during the 30-minute observation period. Simultaneous movements of limbs and trunk count as a single movement episode. Continuous active movement is considered as a single movement.
Abnormal finding (0 points): Fewer than three movement episodes observed, or only isolated, sluggish movements.
Clinical significance: Fetal movement is controlled by higher brain centers and reflects overall neurological integrity. Decreased fetal movement is a well-recognized warning sign of fetal distress and often prompts the initial evaluation that leads to BPP testing. Mothers are typically aware of their fetus's normal movement patterns, and a significant decrease in perceived movement should always be investigated.
Factors affecting movement: Like breathing, fetal movements follow circadian patterns and are influenced by maternal factors. Movement tends to decrease during fetal sleep states and may be affected by maternal medications. Extremely active fetuses may actually be more difficult to assess, as constant motion can make it challenging to capture clear images for other components of the exam.
Fetal tone refers to the presence of flexor tone in the fetal limbs and trunk, demonstrated by active extension with subsequent return to the flexed position. This parameter assesses the function of the subcortical motor system and brainstem reflexes.
Normal finding (2 points): At least one episode of active extension with return to flexion of fetal limbs, trunk, or hand. Opening and closing of the hand qualifies as demonstrating normal tone. Active extension followed by passive return to flexion may also be considered normal.
Abnormal finding (0 points): Slow extension with only partial return to flexion, limbs or trunk in extended position, flaccid posture, or hand held in open, relaxed position without observed flexion.
Clinical significance: Fetal tone is phylogenetically one of the oldest biophysical activities and is controlled by more primitive brain structures. Consequently, it is typically the last parameter to become abnormal in the face of progressive hypoxia. When tone is absent, it generally indicates severe and prolonged fetal compromise. The presence of normal tone with abnormal other parameters may suggest acute rather than chronic compromise.
Assessment considerations: Fetal tone can be subtle and requires careful observation. The examiner should watch for any episode of active flexion-extension, including small movements such as finger movements or wrist flexion. In some cases, external stimulation (vibroacoustic stimulation or manual manipulation) may help elicit movement if the fetus appears to be in a quiet state.
Amniotic fluid is produced primarily by fetal urination after the first trimester and is absorbed through fetal swallowing and across the fetal membranes. The volume of amniotic fluid reflects the balance between production and absorption and serves as an important indicator of placental function and fetal renal perfusion.
Normal finding (2 points): A single vertical pocket of amniotic fluid measuring 2 cm or greater in two perpendicular planes (2 × 1 cm pocket), free of umbilical cord and fetal parts. Alternatively, an amniotic fluid index (AFI) of 5 cm or greater may be used.
Abnormal finding (0 points): Largest vertical pocket less than 2 cm, or AFI less than 5 cm (oligohydramnios).
Clinical significance: Unlike the other four parameters, amniotic fluid volume reflects chronic placental function rather than acute fetal status. Oligohydramnios develops over days to weeks as fetal blood flow is redistributed away from the kidneys to preserve perfusion to vital organs (brain, heart, adrenal glands). A fetus may have normal acute parameters (breathing, movement, tone, reactive heart rate) but abnormal fluid, indicating that while currently compensating, there is underlying chronic uteroplacental insufficiency.
The importance of fluid assessment: A BPP score of 8/10 with the 2 points lost due to oligohydramnios carries different implications than an 8/10 with abnormal breathing (which might simply reflect fetal sleep). Low fluid is associated with increased risk of cord compression during labor and is a more ominous finding that warrants close follow-up or consideration of delivery depending on gestational age.
The non-stress test (NST) uses external cardiotocography to monitor the fetal heart rate pattern over a period of time. It assesses the function of the fetal autonomic nervous system and the ability of the heart to accelerate in response to fetal movement.
Normal/Reactive finding (2 points): Two or more accelerations of the fetal heart rate, with each acceleration rising at least 15 beats per minute above the baseline and lasting at least 15 seconds, observed within a 20-minute window. After 32 weeks gestation, these are the standard criteria; before 32 weeks, accelerations of 10 bpm for 10 seconds are considered reactive.
Abnormal/Non-reactive finding (0 points): Fewer than two qualifying accelerations within 40 minutes of monitoring, or complete absence of accelerations.
Clinical significance: Heart rate reactivity is controlled by the autonomic nervous system and reflects fetal neurological integrity. The presence of accelerations indicates that the fetus has adequate oxygenation to support autonomic function. A non-reactive NST may indicate fetal sleep, prematurity, medication effects, or genuine fetal compromise, which is why it is interpreted in the context of the other BPP parameters.
NST interpretation nuances: Variable decelerations (brief drops in heart rate related to cord compression) are common and not necessarily concerning if they are mild and the fetus remains reactive. However, repetitive deep variables or late decelerations (heart rate drops occurring after contractions) are worrisome findings that warrant immediate evaluation regardless of the BPP score.
The total BPP score ranges from 0 to 10, calculated by summing the scores for all five parameters. Higher scores indicate better fetal well-being, while lower scores suggest increasing degrees of fetal compromise. Management decisions are based on the score, individual parameter results, gestational age, and overall clinical context.
A perfect score indicates that all five parameters are normal, providing strong reassurance that the fetus is currently well-oxygenated and not in distress. The risk of fetal death within one week of a normal BPP is extremely low, estimated at less than 1 per 1,000 tested pregnancies.
Management: Continue routine prenatal care with repeat testing according to the clinical indication that prompted surveillance. For most high-risk conditions, weekly testing is standard, though twice-weekly testing may be indicated for certain high-risk situations such as post-term pregnancy or severe growth restriction.
A score of 8/10 is generally considered normal, but the interpretation depends on which parameter is abnormal. If the non-reactive NST or absent breathing movements account for the lost points, the score is typically still considered reassuring since these parameters are commonly affected by fetal sleep or other benign factors.
With normal amniotic fluid: If the 8/10 score is due to abnormal breathing, movement, or NST but fluid volume is normal, management is typically routine follow-up with repeat testing at the standard interval.
With oligohydramnios: If the 8/10 score is due to low amniotic fluid, the situation requires more careful consideration. Oligohydramnios with otherwise reassuring parameters suggests chronic uteroplacental insufficiency. If the pregnancy is term (≥37 weeks), delivery should be considered. If preterm, closer surveillance (repeat BPP in 24-48 hours) is warranted, along with evaluation for other concerning findings.
An equivocal score of 6 requires careful evaluation and typically mandates repeat testing. The clinical approach depends on gestational age, amniotic fluid status, and the overall clinical picture.
At term (≥37 weeks) with oligohydramnios: Delivery is generally recommended, as the risks of continuing the pregnancy likely outweigh the risks of delivery.
Preterm without oligohydramnios: Repeat BPP in 24 hours. If the repeat score remains 6 or less, delivery should be considered after administration of corticosteroids for fetal lung maturity if less than 34 weeks.
Expected perinatal mortality: Variable, depending on clinical context. The equivocal score warrants heightened attention but does not indicate imminent fetal demise.
An abnormal score of 4 indicates a high probability of fetal acidemia and compromise. Immediate evaluation and strong consideration of delivery are warranted.
At ≥32 weeks: Delivery is typically indicated. If labor is not imminent, cesarean delivery may be appropriate depending on fetal presentation and maternal factors.
At less than 32 weeks: A brief course of corticosteroids for fetal lung maturity may be considered if fetal status allows, but delivery should not be significantly delayed. Continuous fetal monitoring is essential.
Perinatal mortality risk: Approximately 89 per 1,000, or roughly 9%. This underscores the importance of prompt intervention.
A severely abnormal score indicates profound fetal compromise with high likelihood of acidemia and impending fetal death. Immediate delivery is indicated regardless of gestational age, as the risks of continued intrauterine environment exceed even the risks of extreme prematurity.
Management: Emergency delivery, typically by cesarean section unless vaginal delivery is imminent. Neonatal resuscitation team should be present.
Perinatal mortality risk: Ranges from 125 to 600 per 1,000 depending on the score and timing of intervention. Without intervention, intrauterine death is highly likely within days.
The modified BPP is a simplified version of the full assessment that uses only two components: the non-stress test and amniotic fluid measurement. It was developed to provide a faster, more practical surveillance tool while maintaining good predictive accuracy.
Non-stress test: Assesses acute fetal status and CNS function. A reactive NST indicates adequate current oxygenation.
Amniotic fluid index (AFI): Measures the sum of the deepest vertical pocket in each of four uterine quadrants. Normal AFI is 5-25 cm. This component assesses chronic placental function.
Normal modified BPP: Reactive NST AND AFI 5-25 cm. This indicates both adequate acute status and normal chronic placental function. Routine follow-up is appropriate.
Abnormal modified BPP: Non-reactive NST and/or abnormal AFI. If either component is abnormal, a full BPP should be performed to further characterize fetal status.
The modified BPP can be completed in 20 minutes or less and requires less specialized ultrasonography skill than the full assessment. It has good negative predictive value, meaning a normal result is highly reassuring. However, it does not provide the detailed parameter-by-parameter assessment available with the full BPP and may miss certain patterns of fetal compromise. Most protocols recommend proceeding to full BPP when the modified version is abnormal or equivocal.
BPP testing is indicated in pregnancies at increased risk for fetal compromise due to maternal conditions, fetal conditions, or pregnancy complications.
Conditions that impair placental function or oxygen delivery may compromise the fetus:
Certain fetal conditions warrant enhanced surveillance:
Various obstetric complications increase the need for fetal surveillance:
When a fetus experiences progressive hypoxia, the biophysical profile parameters become abnormal in a predictable sequence. Understanding this pattern helps clinicians interpret partial scores and gauge the severity of compromise.
The sequence follows a "last to develop, first to go" principle. Parameters controlled by more recently evolved brain structures are more sensitive to oxygen deprivation and are lost first, while those controlled by primitive brainstem functions are preserved until late in the process.
A fetus with abnormal NST and breathing but normal movement and tone is likely experiencing acute, possibly early compromise. Intervention at this stage may prevent progression. A fetus with loss of all parameters including tone has severe, prolonged hypoxia with likely acidemia and requires immediate delivery. The presence of oligohydramnios at any score level indicates chronic insufficiency regardless of the acute parameter status.
While the BPP is a valuable tool, clinicians must understand its limitations to use it appropriately.
A low BPP score does not always indicate fetal compromise. False positive results (low score in a healthy fetus) may occur due to:
To minimize false positives, observation periods should be adequate (30 minutes for ultrasound components, 40 minutes for NST if initially non-reactive), and clinical context should always be considered.
A normal BPP does not guarantee fetal well-being. The test provides a snapshot in time and cannot predict:
For these reasons, clinical judgment remains essential, and maternal perception of decreased fetal movement should always be investigated even with recent reassuring testing.
The reliability of the BPP depends on the skill of the person performing the examination. Inadequate observation time, poor image quality, or inexperience may lead to inaccurate scoring. Standardized protocols and quality assurance programs help maintain consistency.
A complete biophysical profile typically takes 30-60 minutes. The ultrasound portion requires at least 30 minutes of observation to adequately assess breathing, movement, and tone (parameters may not be continuously present even in healthy fetuses). The non-stress test component typically takes 20-40 minutes. In some cases, a healthy fetus in a sleep cycle may require extended observation before demonstrating all normal parameters.
The biophysical profile is completely non-invasive and poses no known risks to the fetus. Ultrasound has been used in pregnancy for over 50 years with an excellent safety record. The non-stress test simply monitors fetal heart rate through sensors placed on the maternal abdomen with no exposure to radiation or harmful energy.
Fetal sleep is a normal phenomenon and is the most common cause of absent breathing movements or non-reactive heart rate patterns. If initial observations are concerning due to suspected fetal sleep, several strategies may be employed: extended observation time (up to 40 minutes for NST, full 30 minutes for ultrasound), vibroacoustic stimulation (a brief buzzing sound that may arouse the fetus), or rescheduling the test for later in the day when fetal activity may be higher.
Testing frequency depends on the indication. Most high-risk conditions warrant weekly testing. Some situations, such as post-term pregnancy, intrauterine growth restriction, or abnormal prior testing, may require twice-weekly assessment. Your healthcare provider will recommend an appropriate schedule based on your specific circumstances.
A low score triggers additional evaluation and potential intervention. A score of 6 typically prompts repeat testing within 24 hours. Scores of 4 or below generally lead to strong consideration of delivery after weighing fetal and gestational age risks. The specific management depends on the score, which parameters are abnormal, gestational age, and the overall clinical situation.
The biophysical profile remains a cornerstone of antepartum fetal surveillance, providing comprehensive assessment of fetal well-being through evaluation of breathing movements, gross movement, tone, amniotic fluid volume, and heart rate reactivity. With four decades of clinical use and extensive research validation, it offers clinicians a reliable tool for identifying fetuses at risk for adverse outcomes.
Key points to remember:
The test helps identify fetuses at risk while avoiding unnecessary premature delivery, balancing the risks of intervention against the risks of continued surveillance. When properly performed and interpreted in clinical context, the biophysical profile is an invaluable tool for optimizing pregnancy outcomes in high-risk situations.